Angiotensin-converting enzyme inhibition augments the expression of rat elastase-2, an angiotensin II-forming enzyme


Autoria(s): BECARI, Christiane; TEIXEIRA, Felipe R.; OLIVEIRA, Eduardo B.; SALGADO, Maria Cristina O.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2011

Resumo

Becari C, Teixeira FR, Oliveira EB, Salgado MC. Angiotensin-converting enzyme inhibition augments the expression of rat elastase- 2, an angiotensin II-forming enzyme. Am J Physiol Heart Circ Physiol 301: H565-H570, 2011. First published May 20, 2011; doi:10.1152/ajpheart.00534.2010.-Mounting evidence suggest that tissue levels of angiotensin (ANG) II are maintained in animals submitted to chronic angiotensin-converting enzyme (ACE) inhibitor treatment. We examined the expression levels of transcripts for elastase-2, a chymostatin-sensitive serine protease identified as the alternative pathway for ANG II generation from ANG I in the rat vascular tissue and the relative role of ACE-dependent and -independent pathways in generating ANG II in the rat isolated carotid artery rings of spontaneously hypertensive rats (SHR) and Wistar normotensive rats (WNR) treated with enalapril for 7 days. Enalapril treatment decreased blood pressure of SHR only and resulted in significantly more elastase-2 mRNA expression in carotid artery of both enalapril-treated WNR and SHR. Captopril induced a comparable rightward shift of concentration-response curves to ANG I in vehicle and enalapril-treated rats, although this effect was of lesser magnitude in SHR group. Chymostatin induced a rightward shift of the dose response to ANG I in vehicle-treated and a decrease in maximal effect of 22% in enalapril-treated WNR group. Maximal response induced by ANG I was remarkably reduced by chymostatin in enalapril-treated SHR carotid artery (by 80%) compared with controls (by 23%). Our data show that chronic ACE inhibition was associated with augmented functional role of non-ACE pathway in generating ANG II and increased elastase-2 gene expression, suggesting that this protease may contribute as an alternative pathway for ANG II generation when ACE is inhibited in the rat vascular tissue.

FAPESP Fundacao de Amparo a Pesquisa do Estado de Sao Paulo

CNPq Conselho Nacional de Pesquisas Cientificas e Tecnologicas

Identificador

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, v.301, n.2, p.H565-H570, 2011

0363-6135

http://producao.usp.br/handle/BDPI/23779

10.1152/ajpheart.00534.2010

http://dx.doi.org/10.1152/ajpheart.00534.2010

Idioma(s)

eng

Publicador

AMER PHYSIOLOGICAL SOC

Relação

American Journal of Physiology-heart and Circulatory Physiology

Direitos

restrictedAccess

Copyright AMER PHYSIOLOGICAL SOC

Palavras-Chave #serine protease #chymostatin #enalapril #ARTERIAL BED PERFUSATE #SUBSTRATE-SPECIFICITY #RECEPTOR BLOCKERS #HYPERTENSIVE-RATS #HUMAN HEART #IN-VIVO #GENERATION #PATHWAYS #CHYMASE #SYSTEM #Cardiac & Cardiovascular Systems #Physiology #Peripheral Vascular Disease
Tipo

article

original article

publishedVersion